Expertise, insight and commitment to deliver on strategy
Opus’ core team has an ideal mix of experience in science, company formation, patient advocacy, financing and gene therapy drug development.
Board of Directors
Board of Directors
F.M. Kirby Emeritus Professor of Ophthalmology, Perelman School of Medicine, University of Pennsylvania
CEO, Opus Genetics
Former CEO, Santen, Inc.
Managing Director, RD Fund
